METOCLOPRAMIDE
- Product NDC
- 51662-1367
- 11-digit product format
- 516621367
- Labeler code
- 51662
- Product ID
- 51662-1367_ef7bd5a0-02a8-7b66-e053-2995a90a8ffa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- METOCLOPRAMIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA091392
- Marketing category
- ANDA
- Marketing start
- 2019-10-14
- Substance
- METOCLOPRAMIDE HYDROCHLORIDE
- Active strength
- 10 mg/2mL
- Pharmacologic classes
- Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| W1792A2RVD | METOCLOPRAMIDE HYDROCHLORIDE | 54143-57-6 | METOCLOPRAMIDE HYDROCHLORIDE |
| L4YEB44I46 | METOCLOPRAMIDE | 364-62-5 | METOCLOPRAMIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1367-1 | 51662136701 | 1 SYRINGE, GLASS in 1 BLISTER PACK (51662-1367-1) / 2 mL in 1 SYRINGE, GLASS | 2019-10-14 | No | No | Historical |